NATALIE HUXTABLE: Open Payments
NPI 1962167585 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,961 in 95 payments from 14 companies in 2025. Trend: 2023 $2,091 · 2024 $2,159 · 2025 $1,961
Food & beverage: $1,811Education: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $573 |
| Janssen Biotech, Inc. | 17 | $365 |
| Aimmune Therapeutics, Inc. | 10 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $145 |
| Lilly USA, LLC | 6 | $142 |
| Phathom Pharmaceuticals, Inc. | 10 | $135 |
| Celltrion USA Inc. | 3 | $70 |
| Gilead Sciences, Inc. | 2 | $63 |
| Madrigal Pharmaceuticals | 2 | $52 |
Products named: TREMFYA, CREON, RINVOQ, OMVOH, VOQUEZNA, ZENPEP, XIFAXAN, ENTYVIO.
Industry payments across NV — which companies pay providers there.
